Normal inflammatory markers in giant cell arteritis with long-standing cranial and symptomatic large-vessel involvement
暂无分享,去创建一个
[1] J. Fonseca,et al. Giant cell arteritis with normal inflammatory markers: case report and review of the literature , 2020, Clinical Rheumatology.
[2] T. Ruddy,et al. PET/CT for Diagnosis and Management of Large-Vessel Vasculitis , 2019, Current Cardiology Reports.
[3] D. Metze,et al. Nomenclature of cutaneous vasculitides – German translation of the dermatologic addendum to the 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides , 2018, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.
[4] E. Matteson,et al. The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease , 2016, Rheumatology.
[5] E. Matteson,et al. Visual Manifestations in Giant Cell Arteritis: Trend over 5 Decades in a Population-based Cohort , 2015, The Journal of Rheumatology.
[6] G. Hunder,et al. Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis. , 2012, Seminars in arthritis and rheumatism.
[7] D A Bloch,et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. , 2010, Arthritis and rheumatism.
[8] H. Raspe,et al. EULAR recommendations for the management of large vessel vasculitis , 2008, Annals of the rheumatic diseases.
[9] M. Vilardell‐Tarrés,et al. Proposal to decrease the number of negative temporal artery biopsies , 2007, Scandinavian journal of rheumatology.
[10] H. Spiera,et al. Inflammatory disease in older adults. Cranial arteritis. , 2004, Geriatrics.
[11] S. Hayreh,et al. Occult giant cell arteritis: ocular manifestations. , 1998, American journal of ophthalmology.
[12] G. Dutton,et al. Current concepts in giant cell (temporal) arteritis. , 1997, Survey of ophthalmology.
[13] Welton Rc,et al. Temporal arteritis presenting with jaw claudication and normal erythrocyte sedimentation rate. , 1982 .
[14] J. Toole,et al. Temporal arteritis associated with normal sedimentation rate. , 1982, JAMA.
[15] L. Espinoza,et al. Temporal arteritis with normal ESR. , 1980, Archives of internal medicine.
[16] P. Newman. Giant cell arteritis with normal sedimentation rate. , 1978, Archives of neurology.
[17] A. D. Bull,et al. How common is inflammatory marker-negative disease in giant cell arteritis? , 2013, Eye.
[18] P. Merkel,et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. , 2013, Arthritis and rheumatism.
[19] D. Formisano,et al. Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis. , 2009, Rheumatology.
[20] A. de la Sierra,et al. Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis. , 1998, Arthritis and rheumatism.